Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of correlation between mutational status in key EGFR signaling genes and prognosis of stage II colorectal cancer.

Future oncology (London, England) - 1 Jul 2017

Li Li, Ni Bei-Bei, Zhong Qing-Hua, Liu Yan-Hui, Zhang Ming-Hui, Zhang Ke-Ping, Chen Dai-Ci, Wang Lei

Abstract excerpt

AIM: To investigate the relationship between mutations of key genes in the EGFR signaling pathway and the prognosis of stage II colorectal cancer patients without chemotherapy. MATERIALS & METHODS: The incidence of KRAS, NRAS, BRAF, PIK3CA mutations and deficient DNA mismatch repair were assessed in 160 stage II colorectal cancer patients who had been treated by radical operation without adjuvant chemotherapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to GTP Phosphohydrolases

Share to Membrane Proteins

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 28685592
DOI: 10.2217/fon-2017-0040

Genes

BRAF
KRAS
EGFR
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of correlation between mutational status in key EGFR signaling genes and prognosis of stage II colorectal cancer.PMID 28685592Read ↗

Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysisSemantic proximity Read ↗

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.Semantic proximity Read ↗

Risk factors and survival of colorectal cancer patients with RAS/BRAF gene mutationsSemantic proximity Read ↗

Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patientsSemantic proximity Read ↗

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.Semantic proximity Read ↗

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials.Semantic proximity Read ↗

Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity Read ↗

KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal CancerSemantic proximity Read ↗

Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis.Semantic proximity Read ↗

Comparison of the differentially enriched mutations/pathways between stage II and stage IV dMMR/MSI-H colorectal cancer.Semantic proximity Read ↗

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.Semantic proximity Read ↗

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.